4.6 (760) In stock
There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.
Cancers, Free Full-Text
New Targeted Treatments Emerge For Gastric and Esophageal Cancer
Immunotherapy Improves Survival in Advanced Esophageal Cancer - NCI
Types of Gastrectomy
Mayo Clinic Q&A podcast: Esophageal cancer is one of the deadliest
Evolving Immuno-Chemotherapeutic Paradigms in Esophageal and
New Targeted Treatments Emerge for Gastric and Esophageal Cancer
New Targeted Treatments Emerge for Gastric and Esophageal Cancer
Cancers, Free Full-Text
Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer
Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer
Breakthrough Clinical Trial Results in New Standard of Care for
New Gastric & Esophageal Cancer Treatment Breakthrough
Machine Learning Tool Predicts Forms of Esophageal and Stomach
Modern Radiation Therapy Techniques in the Treatment of Esophageal
